Immunological and parasitological parameters after treatment with dexamethasone in murine Schistosoma mansoni

Memorias do Instituto Oswaldo Cruz

Volumn 105, Issue 6, 2010, Pages 729-735

  Aly, Ibrahim R B ^a   Hendawy, Mohamed A ^a   Ali, Eman Ali ^a   Hassan, Eman ^a   Nosseir, Mona M F ^b  

^a Giza   (Egypt)

^b Imbaba   (Egypt)

Author keywords

Cytokines; Morbidity; Schistosomiasis; Treatment

Indexed keywords

ANIMALIA; MURINAE; MUS; SCHISTOSOMA MANSONI;

EID: 77957997213     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762010000600001     Document Type: Article

References (53)

1. Boros DL 1999. T helper cell populations, cytokine dynamics and pathology of the schistosome egg granuloma. Microbes Infect 1: 511-516.
2. Botros SS, Makary EA, Ahmed KM, Ibrahim AM, Nashed NN, El-Nahal HM, Doughty BL, Hassanein HI 2000. Effect of combined praziquantel and recombinant glutathione S-transferase on resistance to reinfection in murine schistosomiasis mansoni. Int J Immunopharmacol 22: 979-988.
3. Brunet LR, Dunne DW, Pearce EJ 1998. Cytokine interaction and immune responses during Schistosoma mansoni infection. Parasitol Today 14: 422-427.
4. Cheever AW 1968. Conditions affecting the accuracy of potassium hydroxide digestion techniques for counting Schistosoma mansoni eggs in tissues. Bull WHO 39: 328-331.
5. Cheever AW, Williams ME, Wynn TA, Finkelman FD, Seder RA, Cox TM, Hieny S, Caspar P, Sher A 1994. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J Immunol 153: 753-759.
6. Coker CM 1957. Effect of cortisone on natural immunity to Schistosoma mansoni in mice. Proc Soc Exp Biol Med 96: 1-3.
7. Czaja MJ, Weiner FR, Takahashi S, Giambrone MA, van der Meide PH, Schellekens H, Biempica L, Zern MA 1989. Gamma-inter-interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatology 10: 795-800.
8. Doenhoff M, Musallam R, Bain J, McGregor A 1978. Studies on the host-parasite relationship in Schistosoma mansoni-infected mice: the immunological dependence of parasite egg excretion. Immunology 35: 771-778.
9. Doumas BT, Watson WA, Biggs HG 1971. Albumin standards and measurement of serum albumin with bromcresol green. Clin Chim Acta 31: 87-96.
10. Duvall RH, DeWitt WB 1967. An improved perfusion technique for recovering adult schistosomes from laboratory animals. Am J Trop Med Hyg 16: 483-486.
11. El-Beshbishy HA 2005. The effect of dimethyl dimethoxy biphenyl dicarboxylate (DDB) against tamoxifen-induced liver injury in rats: DDB use is curative or protective. J Biochem Mol Biol 38: 300-306.
12. Engels D, Chitsulo L, Montresor A, Savioli L 2002. The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Trop 82: 139-146.
13. Fallon PG, Doenhoff MJ 1994. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am J Trop Med Hyg 51: 83-88.
14. Fallon PG, Richardson EJ, McKenzie GJ, McKenzie AN 2000. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol 164: 2585-2591.
15. Franchimont D, Martens H, Hagelstein MT, Louis E, Dewe W, Chrousos GP, Belaiche J, Geenen V 1999. Tumor necrosis factor alphadecreases and interleukin-10 increases, the sensitivity ofhuman monocytesto dexamethasone: potential regulation of the glucocorticoid receptor. J Clin Endocrinol Metab 84: 2834-2839.
16. Fu T, Liu G 1992. Protective effects of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate on damages of isolated rat hepatocytes induced by carbon tetrachloride and D-galactosamine. Biomed Environ Sci 5: 185-194.
17. Gönnert R, Andrews P 1977. Praziquantel, a new board-spectrum antischistosomal agent. Z Parsitenkd 52: 129-150.
18. Gryseels B, Mbaye A, De Vlas SJ, Stelma FF, Guissé F, Van Lieshout L, Faye D, Diop M, Ly A, Tchuem-Tchuenté LA, Engels D, Polman K 2001. Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Trop Med Int Health 6: 864-873.
19. Harrison RA, Doenhoff MJ 1983. Retarded development of Schistosoma mansoni in immunosuppressed mice. Parasitology 86: 429-438.
20. Hegazy IH, Nassar SH, Moussa SM 1997. Comparative effect of tiaprofenic acid and piroxicam alone and as adjuvants to praziquantel in Schistosoma mansoni infected mice. J Egypt Soc Parasitol 27: 397-404.
21. Hermeto MV, Bicalho RS, da Silva RE, de Melo AL, Pereira LH 1994. Oogram studies in mice infected with Schistosoma mansoni and treated with dexamethasone. Rev Inst Med Trop Sao Paulo 36: 99-104.
22. Hermeto MV, Bicalho RS, de Melo AL, Pereira LH 1990. Kinetics of the pulmonary phase of Schistosoma mansoni in mice treated with dexamethasone. Rev Inst Med Trop Sao Paulo 32: 168-171.
23. Hermeto MV, Melo AL, Bicalho RS, Vargas AP, Favaretto FJ, Pereira LH 1993. Dexamethasone does not reduce the worm burden in mice infected with in vivo obtained schistosomules of Schistosoma mansoni. Rev Inst Med Trop Sao Paulo 35: 389-390.
24. Hoffmann KF, Caspar P, Cheever AW, Wynn TA 1998. IFN-gamma, IL-12 and TNF-alpha are required to maintain reduced liver pathology in mice vaccinated with Schistosoma mansoni eggs and IL-12. J Immunol 161: 4201-4210.
25. Hoffmann KF, Cheever AW, Wynn TA 2000. IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J Immunol 164: 6406-6416.
26. Hoffmann KF, James SL, Cheever AW, Wynn TA 1999. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. J Immunol 163: 927-938.
27. Ismail M, Botros S, Metwally A, William S, Farghally A, Tao LF, Day TA, Bennett JL 1999. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am J Trop Med Hyg 60: 932-935.
28. James SP, Hoofnagle JH, Strober W, Jones EA 1983. NIH conference: primary biliary cirrhosis: a model autoimmune disease. Ann Intern Med 99: 500-512.
29. Kamel IA, Cheever AW, Elwi AM, Mosimann A 1977. Worm burden and tissue egg load in mice infected with PZQ-sensitive (CD) and -insensitive (EE10). Trop Med Hyg 26: 696-701.
30. Kind PRH, King EJ 1954. Determination of alkaline phosphatase activity in serum. J Clin Path 7: 322.
31. La Flamme AC, Patton EA, Bauman B, Pearce EJ 2001. IL-4 plays a crucial role in regulating oxidative damage in the liver during schistosomiasis. J Immunol 166: 1903-1911.
32. Lambertucci JR, Modha J, Curtis R, Doenhoff M 1989. The as-association of steroids and schistosomicides in the treatment of experimental schistosomiasis. Trans R Soc Trop Med Hyg 83: 354-357.
33. Liu GT 1987. Clinical uses and pharmacology of DDB. A new drug for chronic viral hepatitis B. Proc CAMS and PUMC 2: 228-233.
34. Liu Z, Cui Q, Fu T 1996. Inducing effect of dimethy-4, 4'-dimethoxy-5, 6,5',6-dimethylenedioxybipheny-2, 2'-dicarboxylate (DDB) on differentiation of leukemia HL-60 cells. Zhonghua Yi Xue Za Zhi 76: 214-217.
35. Mahmoud MR, El-Abhar HA, Saleh S 2002. The effect of Nigella sativa oil against the liver damage induced by Schistosoma mansoni infection in mice. J Ethnopharmacol 70: 1-11.
36. Morrison DD, Vande Waa EA, Bennett JL 1986. Effects of steroids and steroid synthesis inhibitors on fecundity of Schistosoma mansoni in vitro. J Chem Ecol 12: 1901-1908.
37. Nessim NG, Hassan SI, William S, el-Baz H 2000. Effect of the broad spectrum anthelmintic drug flubendazole upon Schistosoma mansoni experimentally infected mice. Arzneimittelforschung 50: 1129-1133.
38. Newman RA, Cutroneo KR 1978. Glucocorticoids selectively decrease the synthesis of hydroxylated collagen peptides. Mol Pharmacol 14: 185-198.
39. Newsome J 1963. Observations on corticosteroid treatment of schistosomiasis in hamsters and baboons. Trans R Soc Trop Med Hyg 57: 425-432.
40. Park EY, Ki SH, Ko MS, Kim CW, Lee MH, Lee YS, Kim SG 2005. Garlic oil and DDB, comprised in a pharmaceutical composition for the treatment of patients with viral hepatitis, prevents acute liver injuries potentiated by glutathione deficiency in rats. Chem Biol Interact 155: 82-96.
41. Pellegrino J, Oliveira CA, Faria J, Cunha AS 1962. New approach to the screening of drugs in experimental schistosomiasis mansoni in mice. Am J Trop Med Hyg 11: 201-215.
42. Pyrrho A dos S, Ramos JA, Neto RM, Silva CS, Lenzi HL, Takiya CM, Gattass CR 2002. Dexamethasone, a drug for attenuation of Schistosoma mansoni infection morbidity. Antimicrob Agents Chemother 46: 3490-3498.
43. Reitman S, Frankel SA 1957. Colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Amer J Clin Pathol 28: 56-63.
44. Rezende SA, Silva-Teixeira DN, Drummond SC, Goes AM 1997. IL-10 plays a role in the modulation of human granulomatous hypersensitivity against Schistosoma mansoni eggs induced by immune complexes. Scand J Immunol 46: 96-102.
45. Salama HM, Amer AR, Hammad OM, El-Sayed WF 2004. Effect of DDB monotherapy and in combination with amantadine hydrochloride and ribavirin in patients with chronic hepatitis C virus infection. Sci Med J ESCME 16: 128-134.
46. Stirewalt MA, Dorsey CH 1974. Schistosoma mansoni: cercarial penetration of host epidermis at the ultrastruetural level. Exp Parasit 35: 1-15.
47. von Lichtenberg 1962. Host response to eggs of S. mansoni. I. Granuloma formation in the unsensitized laboratory mouse. Am J Pathol 41: 711-731.
48. Weichselbaum TE 1946. Measurement of total protein in human serum. Amer J Clin Path Tech 16 (Suppl.): 40-49.
49. WHO - World Health Organization 2002. Prevention and control of schistosomiasis and soil-transmitted helminthiasis. World Health Organ Tech Rep Ser 912: 1-57.
50. Wynn TA, Cheever AW, Jankovic D, Poindexter RW, Caspar P, Lewis FA, Sher A 1995. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376: 594-596.
51. Wynn TA, Cheever AW, Williams ME, Hieny S, Caspar P, Kühn R, Müller W, Sher A 1998. IL-10 regulates liver pathology in acute murine schistosomiasis mansoni but is not required for immune down-modulation of chronic disease. J Immunol 160: 4473-4480.
52. Wynn TA, Morawetz R, Scharton-Kersten T, Hieny S, Morse HC 3rd, Kühn R, Müller W, Cheever AW, Sher A 1997. Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responses in vivo. J Immunol 159: 5014-5023.
53. Yamashita T, Boros DL 1992. IL-4 influences IL-2 production and granulomatous inflammation in murine schistosomiasis mansoni. J Immunol 149: 3659-3664.